魏艳红;尧晨光;奚彩丽;胡康洪;

• 1:湖北工业大学中德生物医学中心发酵工程湖北省协同创新中心

摘要(Abstract)：

自然界拥有丰富的微生物资源,可产生多种天然产物。许多产物含有抗肿瘤的活性成分,包括不同的结构类型:蛋白类、多糖类、蒽环类、有机酸酯类、萜类、生物碱类、大环内酯类及烯二炔类等,已有多种天然产物开发为药物应用于临床。本文就来源于陆地微生物、海洋微生物及共生微生物抗肿瘤药物的种类,微生物来源抗肿瘤药物面临的挑战和应对策略及其优势和发展前景等方面作一综述。

关键词(KeyWords)： 微生物;天然产物;抗肿瘤药

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年项目(31400153);; 湖北省自然科学基金重点项目(2014CFA075)

作者(Authors): 魏艳红;尧晨光;奚彩丽;胡康洪;

DOI: 10.13200/j.cnki.cjb.001697

参考文献(References)：

• [1]NEWMAN D J,CRAGG G M.Natural products as sources of new drugs over the 30 years from 1981 to 2010[J].J Nat Prod,2012,75(3):311-335.
• [2]ZHANG Z,YU X,WANG Z,et al.Anthracyclines potentiate anti-tumor immunity:a new opportunity for chemoimmunotherapy[J].Cancer Lett,2015,369(2):331-335.
• [3]YU Z,PAUL R,BHATTACHARYA C,et al.Structural features facilitating tumor cell targeting and internalization by bleomycin and its disaccharide[J].Biochemistry,2015,54(19):3100-3109.
• [4]SAIF M W,SELLERS S,DIASIO R B,et al.A phase I doseescalation study of edotecarin(J-107088)combined with infusional 5-fluorouracil and leucovorin in patients with advanced/metastatic solid tumors[J].Anticancer Drugs,2010,21(7):716-723.
• [5]LANGEVIN A M,BERNSTEIN M,KUHN J G,et al.A phase II trial of rebeccamycin analogue(NSC#655649)in children with solid tumors:a Children's Oncology Group study[J].Pediatr Blood Cancer,2008,50(3):577-580.
• [6]STRATI P,KANTARJIAN H,RAVANDI F,et al.Phase I/II trial of the combination of midostaurin(PKC412)and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome[J].Am J Hematol,2015,90(4):276-281.
• [7]NIE C,LUO Y,ZHAO X,et al.Caspase-9 mediates Puma activation in UCN-01-induced apoptosis[J].Cell Death Dis,2014,5:e1495.doi:10.1038/cddis.2014.461.
• [8]MARSHALL J L,KINDLER H,DEEKEN J,et al.Phase I trial of orally administered CEP-701,a novel neurotrophin receptor-linked tyrosine kinase inhibitor[J].Invest New Drugs,2005,23(1):31-37.
• [9]ELLESTAD G A.Structural and conformational features relevant to the anti-tumor activity of calicheamicinγ1I[J].Chirality,2011,23(8):660-671.
• [10]MIZUMURA Y.Spicamycin derivative[J].Nihon Rinsho,2006,64(2):322-328.
• [11]YUN I S,LEE M H,RAH D K,et al.Heat shock protein 90inhibitor(17-AAG)induces apoptosis and decreases cell migration/motility of Keloid fibroblasts[J].Plast Reconstr Surg,2015,136(1):44e-53e.
• [12]DIZON D S,DAMSTRUP L,FINKLER N J,et al.Phase II activity of belinostat(PXD-101),carboplatin,and paclitaxel in women with previously treated ovarian cancer[J].Int J Gynecol Cancer,2012,22(6):979-986.
• [13]BROGDON C F,LEE F Y,CANETTA R M.Development of other microtubule-stabilizer families:the epothilones and their derivatives[J].Anticancer Drugs,2014,25(5):599-609.
• [14]HASSFELD J,FAR魬S C,STEINMETZ H,et al.Stereochemical determination of Archazolid A and B,highly potent vacuolar-type ATPase inhibitors from the Myxobacterium archangium gephyra[J].Org Lett,2006,8(21):4751-4754.
• [15]MENHOFER M H,BARTEL D,LIEBL J,et al.In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor[J].Cardiovasc Res,2014,104(2):303-314.
• [16]OLIVO M,ALI-SEYED M.Apoptosis signalling mechanisms in human cancer cells induced by Calphostin-PDT[J].Int J Oncol,2007,30(3):537-548.
• [17]ZHAO F,MAI Q,MA J,et al.Triterpenoids from Inonotus obliquus and their antitumor activities[J].Fitoterapia,2015,101(1):34-40.
• [18]GLAMOCLIJA J,CIRIC A,NIKOLIC M,et al.Chemical characterization and biological activity of Chaga(Inonotus obliquus),a medicinal"mushroom"[J].J Ethnopharmacol,2015,162(1):323-332.
• [19]KWAK T W,SHIN H J,JEONG Y I,et al.Anticancer activity of streptochlorin,a novel antineoplastic agent,in cholangiocarcinoma[J].Drug Des Devel Ther,2015,9(4):2201-2214.
• [20]GULDER T A,MOORE B S.Salinosporamide natural products:Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics[J].Angew Chem Int Ed Engl,2010,49(49):9346-9367.
• [21]SINGH R,SHARMA M,JOSHI P,et al.Clinical status of anti-cancer agents derived from marine sources[J].Anticancer Agents Med Chem,2008,8(6):603-617.
• [22]WYCHE T P,HOU Y,BRAUN D,et al.First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp[J].J Org Chem,2011,76(16):6542-6547.
• [23]TSUKIMOTO M,NAGAOKA M,SHISHIDO Y,et al.Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B[J].J Nat Prod,2011,74(11):2329-2331.
• [24]WEIβC,BOGNER T,SAMMET B,et al.Total synthesis and biological evaluation of fluorinated cryptophycins[J].Beilstein J Org Chem,2012,8(11):2060-2066.
• [25]GOMES N G,LEFRANC F,KIJJOA A,et al.Can some marine-derived fungal metabolites become actual anticancer agents[J].Mar Drugs,2015,13(6):3950-3991.
• [26]MITA M M,SPEAR M A,YEE L K,et al.Phase 1 first-inhuman trial of the vascular disrupting agent plinabulin(NPI-2358)in patients with solid tumors or lymphomas[J].Clin Cancer Res,2010,16(23):5892-5899.
• [27]GUERRERO E,ABAD A,MONTENEGRO G,et al.Analgesic and anti-inflammatory activity of podophyllotoxin derivatives[J].Pharm Biol,2013,51(5):566-572.
• [28]PU X,QU X,CHEN F,et al.Camptothecin-producing endophytic fungus Trichoderma atroviride LY357:isolation,identification,and fermentation conditions optimization for camptothecin production[J].Appl Microbiol Biotechnol,2013,97(21):9365-9375.
• [29]LIU Y Q,LI W Q,MORRIS-NATSCHKE S L,et al.Perspectives on biologically active camptothecin derivatives[J].Med Res Rev,2015,35(4):753-789.
• [30]KUSARI S,LAMSHFT M,KUSARI P,et al.Endophytes are hidden producers of maytansine in Putterlickia roots[J].J Nat Prod,2014,77(12):2577-2584.
• [31]SUDEK S,LOPANIK N B,WAGGONER L E,et al.Identification of the putative bryostatin polyketide synthase gene cluster from"Candidatus Endobugula sertula",the uncultivated microbial symbiont of the marine bryozoan Bugula neritina[J].J Nat Prod,2007,70(1):67-74.
• [32]RATH C M,JANTO B,EARL J,et al.Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743[J].ACS Chem Biol,2011,6(11):1244-1256.
• [33]KINGSTON D G.Modern natural products drug discovery and its relevance to biodiversity conservation[J].J Nat Prod,2011,74(3):496-511.
• [34]DEDYSH S N.Cultivating uncultured bacteria from northern wetlands:knowledge gained and remaining gaps[J].Front Microbiol,2011,2:184.
• [35]M?LLER R.Biosynthesis and heterologous production of epothilones[J].Fortschr Chem Org Naturst,2009,90(1):29-53.
• [36]BROTELLE T,LEMAL R,MOLUCON-CHABROT C,et al.Gemtuzumab ozogamicin for treatment of acute myeloid leukemia[J].Bull Cancer,2014,101(2):211-218.
• [37]BORNSTEIN G G.Antibody drug conjugates:preclinical considerations[J].AAPS J,2015,17(3):525-534.
• [38]GU J Y,GUI Y S,CHEN L R,et al.Use of natural products as chemical library for drug discovery and network pharmacology[J].PLo S One,2013,8(4):e62839.